Biomarin Pharmaceutical Stock Forecast

Buy or Hold candidate since Jun 26, 2026 Gain 2.29%

The BioMarin Pharmaceutical Inc. stock price gained 2.65% on the last trading day (Tuesday, 7th Jul 2026), rising from $58.79 to $60.35. During the last trading day the stock fluctuated 3.26% from a day low at $58.63 to a day high of $60.54. The price has risen in 7 of the last 10 days and is up by 7.96% over the past 2 weeks. Volume fell on the last day by -129 thousand shares and in total, 2 million shares were bought and sold for approximately $92.53 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the upper part of a wide and weak rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $60.78 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 6.25% during the next 3 months and, with a 90% probability hold a price between $54.83 and $64.58 at the end of this 3-month period.

BMRN Signals & Forecast

Mostly positive signals in the chart today. The BioMarin Pharmaceutical Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $58.55 and $55.45. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, May 18, 2026, and so far it has risen 21.50%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. The stock had a Golden Star Signal on Monday, August 25, 2025 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for BioMarin Pharmaceutical Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $57.29 and $54.10. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, BioMarin Pharmaceutical Inc. finds support just below today's level at $57.29. If this is broken, then the next support from accumulated volume will be at $54.10 and $53.24.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $1.91 (3.26%) between high and low. For the last week, the stock has had daily average volatility of 2.53%.

Our recommended stop-loss: $58.50 (-3.06%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 33 days ago.)

Trading Expectations (BMRN) For The Upcoming Trading Day Of Wednesday 8th

For the upcoming trading day on Wednesday, 8th we expect BioMarin Pharmaceutical Inc. to open at $59.84, and during the day (based on 14 day Average True Range), to move between $59.52 and $61.18, which gives a possible trading interval of +/-$1.67 (+/-2.81%) up or down from last closing price. If BioMarin Pharmaceutical Inc. takes out the full calculated possible swing range there will be an estimated 2.81% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $57.29, some $3.06 (5.07%) from the current price of $60.35, our system finds the risk reward attractive.

Is BioMarin Pharmaceutical Inc. stock A Buy?

BioMarin Pharmaceutical Inc. holds several positive signals and is within a weak rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Strong Buy candidate.

Current score: 5.178 Strong Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 8, 2026 - $59.84 ( 0.84%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk